Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025
Initiated ALKAZAR...
Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults
Accelerated approval based on an...
EINDHOVEN, Niederlande, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD und US OTCQX: ONWRY), das führende Neurotechnologieunternehmen, das Pionierarbeit bei Therapien zur Wiederherstellung der Bewegungsfähigkeit, Funktion und Unabhängigkeit von Menschen mit Rückenmarksverletzungen (Spinal cord injury, SCI) und anderen Bewegungseinschränkungen leistet, gibt heute die Ernennung von Lucas Buchanan als nicht geschäftsführendes Mitglied seines Vorstands bekannt.
Military spouses and veterans receive enhanced support in 2025–2026 program
COOKEVILLE, Tenn., Aug. 6, 2025 /PRNewswire/ -- Women in CyberSecurity (WiCyS), the nonprofit organization dedicated to...
Cosmos Health secures financing of up to $300 million to develop an ETH-backed treasury, with remaining proceeds for growth and general working capital
EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the appointment of Lucas Buchanan as a non-executive member of its Board of Directors.
SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ -- A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance...
The cell culture market is anticipated to expand at a rapid pace owing to growing innovations in biotechnologies, and biopharmaceuticals on the back of...